Leitner L, Gruber G, Lohberger B, Kaltenegger H, Leithner A, Sadoghi P
Univ.-Klinik für Orthopädie und Traumatologie, Medizinische Universität Graz, Auenbruggerplatz 5, 8036, Graz, Österreich.
Orthopade. 2019 Jan;48(1):105-116. doi: 10.1007/s00132-018-3643-3.
Platelet-rich plasma (PRP) and growth factors have been increasing in popularity for the orthopedic treatment of degenerative and traumatic diseases. The treatment concept is based on the substitution of growth-inducing substances in tissues with low or absent regeneration capacity (cartilage, tendons) as well as for the induction or further acceleration of growth and regeneration (bone, muscle). This review article provides an overview on the clinical feasibility of usage and a summary of the current study situation.
富含血小板血浆（PRP）和生长因子在退行性和创伤性疾病的骨科治疗中越来越受欢迎。该治疗理念基于用生长诱导物质替代再生能力低或无再生能力的组织（软骨、肌腱），以及诱导或进一步加速生长和再生（骨骼、肌肉）。本文综述提供了关于其临床应用可行性的概述以及当前研究情况的总结。
